[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $ucbjy $UCBJY sees increased mentions and creator activity. Positive sentiment around clinical trial developments is driving engagement. ### About $ucbjy A cryptocurrency or stock ticker symbol. ### Insights [#](/topic/$ucbjy/insights) - $ucbjy mentions is up XXXXX% from the previous X months. ### Engagements: X [#](/topic/$ucbjy/interactions) ---  [Engagements 24-Hour Chart Data](/topic/$ucbjy/time-series/interactions.tsv) **Current Value**: X **Daily Average**: XXX **1 Month**: XXXXX +24% **1-Year High**: XXXXX on 2025-04-29 **1-Year Low**: X on 2025-05-10 | Social Network | X | | -------------- | - | | Engagements | X | ### Mentions: X [#](/topic/$ucbjy/posts_active) ---  [Mentions 24-Hour Chart Data](/topic/$ucbjy/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1 Week**: X +100% **1 Month**: XX +38% **1-Year High**: X on 2025-04-29 **1-Year Low**: X on 2025-04-27 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$ucbjy/contributors_active) ---  [Creators 24-Hour Chart Data](/topic/$ucbjy/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $ucbjy in the last XX hours which is down XX% from X in the previous XX hours **Daily Average**: X **1 Week**: X no change **1 Month**: X +50% **1-Year High**: X on 2025-04-29 **1-Year Low**: X on 2025-04-27 The most influential creators that mention $ucbjy in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@Quantumup1](/creator/twitter/Quantumup1) | X | XXXXX | X | XXX | [View More](/list/creators/$ucbjy/100) **Top assets mentioned** In the posts about $ucbjy in the last XX hours [Johnson & Johnson (JNJ)](/topic/$jnj) [Oruka Therapeutics, Inc. Common Stock (ORKA)](/topic/$orka) [AbbVie Inc (ABBV)](/topic/$abbv) **Top topics mentioned** In the posts about $ucbjy in the last XX hours [$jnj](/topic/$jnj), [$orkas](/topic/$orkas), [$orka](/topic/$orka), [spe](/topic/spe), [$wcrs](/topic/$wcrs), [$tyhoy](/topic/$tyhoy), [$trrvf](/topic/$trrvf), [$abbv](/topic/$abbv), [hc](/topic/hc) ### Top Social Posts [#](/topic/$ucbjy/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "H.C. Wainwright reit'd $ORKA Buy/$45 after Oruka📰that the FDA had cleared its IND application for its Phase 2a trial of ORKA-001 (the company's long-acting anti-IL-23p19 antibody) in moderate-to-severe PsO called EVERLAST-A. $ABBV $PTGX - $JNJ #EDAV25 H.C. Wainwright said in its note: "This program is a randomized double-blind placebo-controlled Phase 2a trial designed to evaluate the safety and efficacy of a single dose level of ORKA-001 in moderate-to-severe psoriasis patients. EVERLAST-A will enroll approximately XX patients randomized 3:1 to receive ORKA-001 or matching placebo. The" [@Quantumup1](/creator/x/Quantumup1) on [X](/post/tweet/1948085842020590074) 2025-07-23 18:20:33 UTC 3529 followers, 1203 engagements "💰 $AACAY $AMIGY $BCKIY $BIRDF $CAIXY $CLST $COST $CPHRF $CQP $DELKY $DLMAF $EFSG $ESYJY $FMS $GATX $GBOOY $GVDNY $JBTC $JINFF $MCCRF $MITFY $MLLGF $MQBKY $MTYFF $PRMRF $PSYTF $PUGBY $RDWR $RECT $RLGT $SEKEY $SPE $TCYSF $TMXXF $TRRVF $TYHOY $UCBJY $WCRS Like 😎 🙏 #Unus" [@JimyTuits](/creator/x/JimyTuits) on [X](/post/tweet/1948021533273932028) 2025-07-23 14:05:00 UTC XXX followers, XX engagements "Stifel reiterated $ORKA Buy-$47 after $ORKA's disclosure of the IND clearance for ORKA-001 and then catching up w/ mgmt. $ABBV $PTGX $JNJ #EADV25 $UCBJY $MLTX Stifel said in its note: "We caught up with management who noted that the IND clearance was based on interim Ph1 data (safety/tolerability) and Ph2a sites are open and actively enrolling -- Ph1 results to be presented at #EADV in September. Recall ORKA-001 is a next-gen IL-23p19 which is designed to explore greater exposure and improved dosing vs. mega-blockbuster Skyrizi based on exploratory IST results in Psoriasis demonstrating" [@Quantumup1](/creator/x/Quantumup1) on [X](/post/tweet/1947283589118198123) 2025-07-21 13:12:41 UTC 3530 followers, 4206 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$UCBJY sees increased mentions and creator activity. Positive sentiment around clinical trial developments is driving engagement.
A cryptocurrency or stock ticker symbol.
Engagements 24-Hour Chart Data
Current Value: X
Daily Average: XXX
1 Month: XXXXX +24%
1-Year High: XXXXX on 2025-04-29
1-Year Low: X on 2025-05-10
Social Network | X |
---|---|
Engagements | X |
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: X +100%
1 Month: XX +38%
1-Year High: X on 2025-04-29
1-Year Low: X on 2025-04-27
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $ucbjy in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: X
1 Week: X no change
1 Month: X +50%
1-Year High: X on 2025-04-29
1-Year Low: X on 2025-04-27
The most influential creators that mention $ucbjy in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@Quantumup1 | X | XXXXX | X | XXX |
Top assets mentioned In the posts about $ucbjy in the last XX hours
Johnson & Johnson (JNJ) Oruka Therapeutics, Inc. Common Stock (ORKA) AbbVie Inc (ABBV)
Top topics mentioned In the posts about $ucbjy in the last XX hours
$jnj, $orkas, $orka, spe, $wcrs, $tyhoy, $trrvf, $abbv, hc
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"H.C. Wainwright reit'd $ORKA Buy/$45 after Oruka📰that the FDA had cleared its IND application for its Phase 2a trial of ORKA-001 (the company's long-acting anti-IL-23p19 antibody) in moderate-to-severe PsO called EVERLAST-A. $ABBV $PTGX - $JNJ #EDAV25 H.C. Wainwright said in its note: "This program is a randomized double-blind placebo-controlled Phase 2a trial designed to evaluate the safety and efficacy of a single dose level of ORKA-001 in moderate-to-severe psoriasis patients. EVERLAST-A will enroll approximately XX patients randomized 3:1 to receive ORKA-001 or matching placebo. The"
@Quantumup1 on X 2025-07-23 18:20:33 UTC 3529 followers, 1203 engagements
"💰 $AACAY $AMIGY $BCKIY $BIRDF $CAIXY $CLST $COST $CPHRF $CQP $DELKY $DLMAF $EFSG $ESYJY $FMS $GATX $GBOOY $GVDNY $JBTC $JINFF $MCCRF $MITFY $MLLGF $MQBKY $MTYFF $PRMRF $PSYTF $PUGBY $RDWR $RECT $RLGT $SEKEY $SPE $TCYSF $TMXXF $TRRVF $TYHOY $UCBJY $WCRS Like 😎 🙏 #Unus"
@JimyTuits on X 2025-07-23 14:05:00 UTC XXX followers, XX engagements
"Stifel reiterated $ORKA Buy-$47 after $ORKA's disclosure of the IND clearance for ORKA-001 and then catching up w/ mgmt. $ABBV $PTGX $JNJ #EADV25 $UCBJY $MLTX Stifel said in its note: "We caught up with management who noted that the IND clearance was based on interim Ph1 data (safety/tolerability) and Ph2a sites are open and actively enrolling -- Ph1 results to be presented at #EADV in September. Recall ORKA-001 is a next-gen IL-23p19 which is designed to explore greater exposure and improved dosing vs. mega-blockbuster Skyrizi based on exploratory IST results in Psoriasis demonstrating"
@Quantumup1 on X 2025-07-21 13:12:41 UTC 3530 followers, 4206 engagements
/topic/$ucbjy